39 results
8-K/A
EX-99.1
FENC
Fennec Pharmaceuticals Inc
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
and Usage of PEDMARK® Drove Quarterly Revenue Growth of 98% ~
~Fennec Expands Leadership Team with the Appointment of Adrian Haigh as Chief Operating … in evaluating business development opportunities and preparing global commercial operations, and we are pleased to have him on our leadership team
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
and Usage of PEDMARK® Drove Quarterly Revenue Growth of 98% ~
~Fennec Expands Leadership Team with the Appointment of Adrian Haigh as Chief Operating … in evaluating business development opportunities and preparing global commercial operations, and we are pleased to have him on our leadership team
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
and Usage of PEDMARK® Drove Quarterly Revenue Growth of 98% ~
~Fennec Expands Leadership Team with the Appointment of Adrian Haigh as Chief Operating … in evaluating business development opportunities and preparing global commercial operations, and we are pleased to have him on our leadership team
8-K
EX-99.1
571xpo89sbplivmg1t
29 Apr 14
Adherex Appoints Two Independent Directors
12:00am
8-K
EX-99.1
fci3nxdsb kcarar
9 Sep 19
Fennec Appoints Shubh Goel As Chief Commercial Officer
4:13pm
8-K
l13femd8 pna5
9 Sep 19
Fennec Appoints Shubh Goel As Chief Commercial Officer
4:13pm
8-K
bgr 6dviq
26 Aug 11
Adherex Announces Completion of Reverse Stock Split and Continuance to British Columbia
12:00am
8-K
EX-99.1
bgasxrd9 1hf
31 Jan 22
Fennec Pharmaceuticals Announces Management Change
8:32am
8-K
EX-99.1
z3l5hj8
10 Dec 12
Adherex Reports Positive Preliminary Interim Phase II Results
12:00am
CORRESP
dx8p89
12 Jan 11
Correspondence with SEC
12:00am
424B3
xw5mvw
26 Aug 11
Prospectus supplement
12:00am